Advances in Cervical Cancer-AM2018
This session will review the current oncogenesis, prevention, detection, workup and initial therapeutic approach to women with cervical cancer. Special attention will be paid to practical considerations in the design of conformal external beam volumes, the use of chemotherapy and the integration of advanced imaging into brachytherapy planning, particularly MRI. Many of these technologies offer the possibilities with improving the efficacy of treatment while reducing the potential for injury, therefore improving the overall value of radiation therapy in the treatment of this disease.
This activity is available from January 3, 2019 through 11:59 p.m. Eastern time on January 2, 2021.
This activity was originally recorded at ASTRO’s 2018 Annual Meeting, October 22-24, 2018 in San Antonio, TX.
The meeting is designed to meet the interests of radiation oncologists, medical oncologists, surgeons, radiation oncology residents, radiation physicists, nurses, radiation therapists, and radiation dosimetrists.
- State the oncogenesis, prevention, workup and initial management of cervical cancer.
- Design optimal external beam volumes for treatment of the pelvis and para-aortic chains, and appropriately integrate chemotherapy if required.
- Review the need and benefits of brachytherapy, as well as to understand the concepts behind image guided brachytherapy, including optimal dosing for tumor control and prevention of toxicity.
Mitchell Kamrava, MD is employed by Cedars Sinai Medical Center and recieves compensation/remuneration/funding from Augmenix.
Lilie Lin, MD is employed by MD Anderson Cancer Center and has no disclosures to declare.
Additionally, the SA-CME Task Force and the CME/MOC Committee had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.25 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.25 self-assessment credits.
- 0.00 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- No refunds, extensions or substitutions will be made for those registrants who, for any reason, were unable to attend or were tardy for the session.
- No credits will be granted and no refunds, exchanges or transfers will be given to those who do not pass.
- ASTRO staff cannot make modifications to your submitted materials.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.